...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The American journal of hospice and palliative care >Management of symptomatic ascites in recurrent ovarian cancer patients using an intra-abdominal semi-permanent catheter.
【24h】

Management of symptomatic ascites in recurrent ovarian cancer patients using an intra-abdominal semi-permanent catheter.

机译：使用腹腔内半永久性导管治疗复发性卵巢癌患者的症状性腹水。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Ascites is commonly present in women with advanced-stage ovarian cancer. No standardized protocol exists for the treatment of the patient with recurrent ovarian cancer and rapidly reaccumulating malignant ascites. Palliation of symptoms is most commonly achieved through repeated paracentesis, a procedure that potentially results in injury to intra-abdominal organs, infection, and patient discomfort. Our goal was to improve patient comfort by alleviating symptoms and reducing the need for paracentesis. The Pleurx' catheter offers a number of potential advantages over traditional treatment modalities. Clearly, larger study numbers are required to quantify the morbidity associated with the Pleurx catheter.
机译：晚期卵巢癌女性通常存在腹水。目前尚无用于治疗复发性卵巢癌和恶性腹水迅速复发的标准化方案。症状缓解通常是通过反复的穿刺术实现的，该过程可能会导致腹腔内器官损伤，感染和患者不适。我们的目标是通过缓解症状和减少穿刺术来提高患者的舒适度。与传统的治疗方式相比，Pleurx的导管具有许多潜在的优势。显然，需要更大的研究数量来量化与Pleurx导管相关的发病率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号